Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moullier

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Experimental Eye Research|July 5, 2011
Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retinaBéatrice Joussemet, Brahim Belbellaa, Alexandra Mendes-Madeira, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2010
Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectorsElsa Lhériteau, Lyse Libeau, Alexandra Mendes-Madeira, et al.
Frontiers in Immunology|February 11, 2020
Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8<sup>+</sup> T Cells in Human Donors Allows the Detection of a T<sub>EMRA</sub> SubpopulationCéline Vandamme, Rebecca Xicluna, Leslie Hesnard, et al.
Molecular Therapy. Nucleic Acids|March 4, 2018
RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target EffectClaire Domenger, Marine Allais, Virginie François, et al.
Plos One|September 24, 2014
Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primatesCaroline Le Guiner, Knut Stieger, Alice Toromanoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2005
Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brainNathalie Provost, Guylène Le Meur, Michel Weber, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2016
Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCRSusan D'Costa, Veronique Blouin, Frederic Broucque, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 31, 2006
Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectorsKnut Stieger, Guylène Le Meur, Françoise Lasne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2008
Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primatesKnut Stieger, Josef Schroeder, Nathalie Provost, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2008
Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primatesAurélie Moreau, Rita Vicente, Laurence Dubreil, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Experimental Eye Research|July 5, 2011
Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retinaBéatrice Joussemet, Brahim Belbellaa, Alexandra Mendes-Madeira, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2010
Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectorsElsa Lhériteau, Lyse Libeau, Alexandra Mendes-Madeira, et al.
Frontiers in Immunology|February 11, 2020
Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8<sup>+</sup> T Cells in Human Donors Allows the Detection of a T<sub>EMRA</sub> SubpopulationCéline Vandamme, Rebecca Xicluna, Leslie Hesnard, et al.
Molecular Therapy. Nucleic Acids|March 4, 2018
RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target EffectClaire Domenger, Marine Allais, Virginie François, et al.
Plos One|September 24, 2014
Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primatesCaroline Le Guiner, Knut Stieger, Alice Toromanoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2005
Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brainNathalie Provost, Guylène Le Meur, Michel Weber, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2016
Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCRSusan D'Costa, Veronique Blouin, Frederic Broucque, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 31, 2006
Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectorsKnut Stieger, Guylène Le Meur, Françoise Lasne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2008
Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primatesKnut Stieger, Josef Schroeder, Nathalie Provost, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2008
Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primatesAurélie Moreau, Rita Vicente, Laurence Dubreil, et al.
Pageof 10